Articles by William Looney - Pharmaceutical Executive


Articles by William Looney

Novartis: LEADing in Emerging Markets

Mar 12, 2012

With growth as its guiding light, Novartis has big plans for the emerging markets. Pharm Exec sits down with CEO Joe Jimenez to understand what it will take the company to best the competition.

The Maestros

Mar 1, 2012

Pharm Exec's latest EAB meeting offered a frank exchange on this magazine's digital future.

Brand Success: It's Not Serendipity

Feb 1, 2012

A new generation of products for inflammatory disease is coming forward, promising better promise and possibly a cure.

Pharma 2012: Hard Times Before the Harvest

Jan 1, 2012

The challenge for 2012 is that many new treatments may not complete the move from 'bench to bedside' in time to plug the yawning revenue gap.

RaQualia's New Spin on the Startup

Dec 1, 2011

Pharm Exec sits down with CEO Atsushi Nagahisa to explore how culture can maximize the value of an inherited portfolio

The Medicines Adherence Challenge

Dec 1, 2011

Keeping skittish patients on their medicines ought to be a strategic priority for Big Pharma — but is it? Pharm Exec convenes an expert round table to examine how best to make progress and agree on some practical steps for incorporation in the campaign agenda.

Was 2011 the End of the Beginning?

Dec 1, 2011

The gap in perception is one of industry's biggest problems because it adds ballast to the idea that medicines are just a simple procurement item, writes William Looney.

R&D Costs: It's Industry's Problem

Nov 1, 2011

If high prices that lower access are attributable to a flawed R&D model, can industry embrace delivering better results at lower costs.

Pharm Exec:  30 Years,  30 Leaders

Oct 1, 2011

Pharm Exec celebrates its 30th birthday with a gathering of 30 of the industry's key influencers of the last three decades.


Click here